Skip to contentClarengateINTELLIGENCE
Companies/14715294

Axovia Therapeutics Ltd

Research and experimental development on biotechnology · London

ActiveUnited KingdomIncorporated 2023Private Limited Company
Register Ask analyst

Financial position

Accounts to 2025-12-31 · GBP · Company accounts

Net assets
£3,217,729
Cash
£2,682,552
Turnover
—
Profit / loss
—
Current assets
£3,100,330
Creditors < 1 year
£238,597
Equity
£3,217,729
Average employees
8

Balance-sheet trend

GBP · company

Financial statements

Selected figures from the best-ranked available filing for each period. Missing values remain unknown.

3 periods
Reported figures2025-12-3112 months · Company2024-12-3112 months · Company2023-12-31Company
Balance sheet
Net assets£3,217,729£271,023£1,751,946
Equity£3,217,729£271,023£1,751,946
Assets
Fixed assets£644,613£644,613£644,613
Current assets£3,100,330£5,032,784£1,257,932
Cash at bank£2,682,552£4,569,651—
Debtors£417,778£463,133—
Liabilities
Creditors within one year£238,597£129,572£102,804
Creditors after one year—£5,100,000£0
Provisions£288,617£176,802—
Net current assets£2,861,733£4,903,212£1,163,698
Assets less current liabilities£3,506,346£5,547,825£1,808,311
People & pay
Average employees88—
Source evidenceView filing View filing View filing

Secured borrowing

Registered charges, lenders and security interests.

Charges and related records

0 outstanding charges
Show 3 satisfied / released
Fixed · created 2025-02-27 · satisfied 2026-03-06
—
Satisfied
Fixed · created 2023-10-18 · satisfied 2026-03-06
—
Satisfied
Fixed · created 2023-10-05 · satisfied 2025-03-04
—
Satisfied